PAI

Palo Alto Investors Portfolio holdings

AUM $470M
1-Year Return 2.57%
This Quarter Return
+12.33%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.81B
AUM Growth
+$59.5M
Cap. Flow
-$83.9M
Cap. Flow %
-4.62%
Top 10 Hldgs %
73.95%
Holding
42
New
Increased
9
Reduced
3
Closed

Sector Composition

1 Healthcare 95.6%
2 Financials 3.69%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KLDO
26
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$5.85M 0.32%
786,400
DNTH icon
27
Dianthus Therapeutics
DNTH
$1.2B
$4.23M 0.23%
27,019
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$3.71M 0.2%
214,700
KZR icon
29
Kezar Life Sciences
KZR
$28.9M
$3.56M 0.2%
65,620
RIGL icon
30
Rigel Pharmaceuticals
RIGL
$681M
$2.83M 0.16%
65,240
CYTK icon
31
Cytokinetics
CYTK
$6.12B
$2.45M 0.13%
123,686
TVTX icon
32
Travere Therapeutics
TVTX
$2.09B
$2.42M 0.13%
166,069
ALIM
33
DELISTED
Alimera Sciences, Inc.
ALIM
$1.83M 0.1%
200,919
ALDX icon
34
Aldeyra Therapeutics
ALDX
$324M
$1.82M 0.1%
160,800
ATNX
35
DELISTED
Athenex, Inc. Common Stock
ATNX
$1.47M 0.08%
15,910
TCMD icon
36
Tactile Systems Technology
TCMD
$301M
$1.41M 0.08%
27,100
MRNS
37
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$562K 0.03%
31,330
SYRS
38
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$439K 0.02%
8,060
VIRX
39
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$377K 0.02%
33,212
URGN icon
40
UroGen Pharma
URGN
$869M
$374K 0.02%
24,500
ACGN
41
DELISTED
Aceragen, Inc. Common Stock
ACGN
$92K 0.01%
4,537
NERV icon
42
Minerva Neurosciences
NERV
$15.2M
$84K ﹤0.01%
4,540